News

Eris Lifesciences supports innovation in CME, launches Metabolic Roadinar

The first-of-its-kind initiative aims to disrupt the CME landscape and give medical communication a new dimension 

Eris Lifesciences supports the first-of-its-kind initiative presented by the Metabolic Health Digest, the first edition of the Metabolic Roadinar, an educational travelogue featuring 18 well-known doctors from across the country spread across nine episodes. 

Having covered 45,000+ medical practitioners since the start of the pandemic through digital interactions, Eris has been at the forefront in delivering knowledge sessions for doctors in the fields of diabetes, heart failure, Covid impact on cardiometabolic health and general immunity. Eris has carved out a niche for itself in the cardio-metabolic space through its unique patient care initiatives platform and ongoing investment in India-centric studies to generate cutting-edge scientific evidence based on the local population.  

The Metabolic Roadinar is in line with Eris’ commitment to support innovative thinking and deliver future-forward, critical information to the medical fraternity. The Roadinar has been conceptualised by Dr Rajiv Kovil, a diabetologist in Mumbai. The list of 18 doctors who will be a part of this Roadinar includes prominent names such as Dr Ambrish Mithal, Dr Shashank Joshi and Dr Tejas Shah; the Roadinar features doctors from across cities such as Delhi, Mumbai, Ahmedabad, Bengaluru, Pune, Aurangabad and Kolkata.  

Amit Bakshi, CMD, Eris Lifesciences said, “We want to bring together a fresh perspective and encourage newer ideas. Metabolic Roadinar, is an innovative way of delivering CMEs that retains its essence and at the same time opens avenues for disruption in the approach towards CMEs in future. We are happy to support innovation in this field and this becomes a trendsetter for years to come.” 

 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
IndiaMedToday
Close
Close